PHARMEXCIL PHARMACEUTICALS EXPORT PROMOTION COUNCIL (Set up by Ministry of Commerce  & Industry, Govt. of India) Dt: 19.02.2010 “PHARMEXCIL NEWS COMPILATION” Dt:19.02.2010 To The Managing Director /CEO Dear Sir/Madam,   Pharmexcil Compilation     Date Category Subject Source Feb 19 2010 International Markets Aiming for growth in Indonesia, Philippines. Fierce Pharma Feb 19 2010 General Wockhardt Swiss arm scouts for foreign lenders Economic Times Feb 19 2010 General Pharming Success, Baddi-Barotiwala-Nalagarh is one of the largest pharma manufacturing hub in the northern region. Economic Times Feb 19 2010 General Ranbaxy stock price soars on US gains Business Standard Feb 19 2010 General DRL to move 25% more Betapharm production to India. Business Standard Feb 19 2010 General GlaxoSmithKline Pharma: In sound health Business Standard Feb 19 2010 IPR / India Patent office has 70,000 patent applications to be disposed of: P H Kurian Pharmabiz Feb 18 2010 IPR / India India Seeks Observer status at WTO Govt. supply talks Economic Times Feb 18 2010 General Gujrat Pharma industry seeks to include more sops in Union Budget. Financial Express Feb 18 2010 IPR / India Experts, NGOs oppose CII-GWU summit on IP for strong patent regime in India Pharmabiz Feb 18 2010 General Glenmark: Bright future in the UK and beyond Economic Times Feb 18 2010 Counterfeit / No Cure For Fake Drugs. The Middle East Struggles with an Influx of Counterfeit Medicines The wall street Journal Bottom of Form International To Access All Previous News  Click here Other Pharma Related News   Date Category Subject Source Feb 19 2010 Substandard Maharashtra FDA finds 39 not-of-standard-quality drug samples during inspection in Jan Pharmabiz Feb 19 2010 Govt./ Regulation Health ministry revokes suspension of mfg license of CRI Kasauli, operations to start next week. Pharmabiz Feb 18 2010 International business Abbots offers to pick up 20% in Solvay. Business Standard Feb 18 2010 Global Market  Top 10 drugs from new Merck, new Pfizer. FiercePharma Please also see:  Task Force Report on pharmaceuticals Regards, Dr.P.V.Appaji Executive Director Back